A Third Dose of SARS-CoV-2 mRNA Vaccine Improves Immune Response in Chronic Kidney Disease Patients

Chronic kidney disease (CKD) patients have an increased risk of morbidity and mortality following SARS-CoV-2 infection. Vaccination in these patients is prioritized, and monitoring of the immune response is paramount to define further vaccination strategies. This prospective study included a cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Poli, Maria Cecilia, Vial, Cecilia, Rey-Jurado, Emma, González, Natalia, Cortés, Lina Jimena, Hormazabal, Juan, Ramírez-Riffo, Carolina, de la Cruz, Javiera, Ulloa, Camilo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221173/
https://www.ncbi.nlm.nih.gov/pubmed/37243116
http://dx.doi.org/10.3390/vaccines11051012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221173/
https://www.ncbi.nlm.nih.gov/pubmed/37243116
http://dx.doi.org/10.3390/vaccines11051012

Ejemplares similares